CompletedNot Applicable

Effect Of Bath Wıth Chlorexıdıne On Protectıon Of Skın Integrıty And Preventıon Of Hospıtal Infectıon

Turkey (Türkiye)68 participantsStarted 2022-09-01

Plain-language summary

The study was designed in a randomized controlled experimental design type to determine the effect of a 2% chlorhexidine bath applied in the pediatric intensive care unit on protecting skin integrity and preventing hospital-acquired infection. Research data were collected from pediatric patients aged 2 months to 18 years old, who were treated in the Pediatric Intensive Care Unit of a tertiary education and research hospital between September 2022 and September 2023. In data collection; "Child Follow-up Form", "Skin Integrity and Nosocomial Infection Follow-up Form", and "Northampton Pediatric Skin Evaluation Scale (CCRS)" were used. The data were evaluated with appropriate statistical methods in SPSS (Statistical Package for Social Sciences) for Windows 24.0 package program.

Who can participate

Age range

2 Months – 18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- • Between 2 months -18 years old, * Receiving treatment in the pediatric intensive care unit for at least three days, * No nosocomial infection before the first 48-72 hours of hospitalization, * Not using antibiotics in the first hospitalization, * Not having any skin problems, * Evaluated as low or moderate by the Northempton pediatric skin rating scale, * Children who were accepted to be included in the study by their parents were included in the study. Exclusion Criteria: * • Positive blood cultures at the first admission to the clinic, * Having a diagnosis and treatment that suppresses the immune system, * Followed up with the diagnosis of cancer, * Receiving steroid therapy for 10 days or more, * Having arterial catheterization, * In the postoperative period, the integrity of the skin is impaired, the operation scar, * Having a skin disease known to affect the skin barrier function, * Those with burn injuries, * Children with a known history of allergy to chlorhexidine were not included in the study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

skin integrity

Timeframe: From admission to discharge, up to 3 days

hospital acquired infection

Timeframe: From admission to discharge, up to 3 days

Trial details

NCT IDNCT05844683

SponsorOkan University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-25

View on ClinicalTrials.gov More Health Care Associated Infection trials